Seguimiento farmacoterapéutico a pacientes con diabetes mellitus tipo 2 del Centro de Salud I-4 Nauta

• Autores: Raygada-Ramirez, Patricia, Ramos-Cevallos, Norma
• Formato: artículo
• Fecha de Publicación: 2022
• Institución: Universidad Nacional Mayor de San Marcos
• Repositorio: Revistas - Universidad Nacional Mayor de San Marcos
• Lenguaje: español
• OAI Identifier: oai:ojs.csi.unmsm:article/24863
• Enlace del recurso: https://revistasinvestigacion.unmsm.edu.pe/index.php/farma/article/view/24863
• Nivel de acceso: acceso abierto
• Materia: pharmacotherapeutic follow-up (PFU); drug related problems (DRP); pharmaceutical intervention; diabetes mellitus type 2; seguimiento farmacoterapéutico (SFT); problemas relacionados con medicamentos (PRM); intervención farmacéutica; diabetes mellitus tipo 2

Diabetes mellitus is a chronic disease that is increasing worldwide and in Peru; so that patients suffering from this disease may present problems related to medications. The objective of this research was to provide a Pharmacotherapeutic Follow-up (SFT) service to older adult patients diagnosed with type 2 diabetes mellitus; at the same time identify the type of problems and the causes that generate the Problems Related to Medications (PRM); as well as pharmaceutical intervention (FI) and pharmacotherapeutic compliance of patients for prevention. It is a prospective, descriptive, and longitudinal study. Using the tools of the Dáder methodology to carry out pharmacotherapeutic follow-up (SFT), the evaluation of compliance and knowledge was carried out using the Morisky-Green test; Patients with type 2 diabetes mellitus, who were treated at the I-4 Nauta Health Center, were evaluated for three months. 13 patients were included in the study. In total, 13 drug-related problems (DRPs) were detected, with 1 DRP (53.8%) being the most frequent, followed by 4 DRPs (15.4%). Inadequate conservation (23.1%) and non-compliance with treatment (30.8%) were identified as the most frequent causes. Through the SFT, the type and causes that generate drug-related problems (PRM) were identified, and at the same time it was observed that 61.5% corresponded to need, 23.1% to effectiveness, and 15.4% to safety. It was concluded that the optimization of the SFT is positively influenced in the improvement of the patient’s health status.